Insight Molecular Diagnostics Inc. Impairment of Long-Lived Assets to be Disposed of
Insight Molecular Diagnostics Inc. (IMDX) reported Impairment of Long-Lived Assets to be Disposed of of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf · last filed 2023-04-12
- Insight Molecular Diagnostics Inc. impairment of long-lived assets to be disposed of for the quarter ending 2020-12-31 was $334.00K.
- Insight Molecular Diagnostics Inc. impairment of long-lived assets to be disposed of for the quarter ending 2020-09-30 was -$334.00K.
- Insight Molecular Diagnostics Inc. impairment of long-lived assets to be disposed of for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Insight Molecular Diagnostics Inc. impairment of long-lived assets to be disposed of for fiscal 2020 was $422.00K.
| Period end | Impairment of Long-Lived Assets to be Disposed of 3 month | Impairment of Long-Lived Assets to be Disposed of 6 month | Impairment of Long-Lived Assets to be Disposed of 9 month | Impairment of Long-Lived Assets to be Disposed of 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-04-12 | |||
| 2020-12-31 | $334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-03-11 | $422.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | -$334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $88.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $422.00K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |